Feasibility and Safety of Minimally Invasive Gastrectomy Post-Chemotherapy

Examining minimally invasive gastrectomy post-preoperative chemotherapy for advanced gastric cancer, this study included 150 patients, assessing safety and feasibility. The overall morbidity rate was 12%, with a higher incidence in total/proximal gastrectomy plus splenectomy cases. Robotic gastrectomy, especially in cases involving splenectomy, demonstrated significantly lower postoperative complications compared to the laparoscopic approach. The findings support the feasibility and safety of minimally invasive gastrectomy following preoperative chemotherapy, with robotic assistance potentially enhancing surgical safety.